Cascades Reports Strong Q2 2026 Earnings Amid Tariff Concerns
Event summary
- Sales increased to $1,219 million in Q2 2026, up from $1,125 million in Q1 2026 and $1,187 million in Q2 2025.
- Operating income was $58 million, compared to $81 million in Q1 2026 and $36 million in Q2 2025.
- Adjusted EBITDA (A) reached $140 million, a 2% increase from the same period last year.
- Net debt decreased modestly to $1,879 million despite unfavourable exchange rate movements.
- U.S. tariffs on certain tissue and packaging products could impact operations.
The big picture
Cascades' strong Q2 2026 results reflect operational improvements and cost reduction initiatives. However, the company faces potential headwinds from new U.S. tariffs on tissue and packaging products. The strategic focus remains on profitability improvement and disciplined capital allocation amid geopolitical uncertainties.
What we're watching
- Tariff Mitigation
- How Cascades' tactical initiatives will mitigate the potential financial impact of U.S. tariffs.
- Earnings Trajectory
- Whether Cascades can sustain its earnings momentum despite geopolitical uncertainties and inflationary pressures.
- Asset Sales Progress
- The pace at which Cascades will achieve its $230 million asset sale objective, now expected in early 2027.
Related topics